跳至主要内容
临床试验/EUCTR2018-000726-63-DK
EUCTR2018-000726-63-DK进行中(未招募)1 期

Pre- and Postoperative Imaging and Monitoring of Patients with Primary Hyperparathyroidism:Preoperative imaging in primary hyperparathyroidism using dual-isotope subtraction scintigraphy (SPECT/CT) and 11C-Choline PET/CT

Department of Clinical Physiology and Nuclear Medicine, Herlev and Gentofte Hospital0 个研究点目标入组 200 人开始时间: 2018年6月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients diagnosed with primary hyperparathyroidism are eligible for inclusion when referred for dual-isotope subtraction scintigraphy and parathyroidectomy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • 1) The patient does not wish to participate
  • 2) The patient is unable to give informed consent
  • 3) The patient is <18 years old
  • 4) The patient is unable to cooperate e.g. severe claustrophobia
  • 5) Other reason for secondary osteoporosis (e.g. treatment with glucocorticoids)
  • 6) Current pregnancy or breastfeeding
  • 7) Known hypothyroidism
  • 8) Known cancer (other than basal cell carcinoma)
  • 9) Hypersensitivity to the reseaerch drug

研究者

发起方
Department of Clinical Physiology and Nuclear Medicine, Herlev and Gentofte Hospital

相似试验